OvaScience Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 59

Employees

  • Latest Deal Type
  • M&A

OvaScience General Information

Description

Millendo Therapeutics Inc is a late-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases. Its lead asset, livoletide, is an unacylated ghrelin analogue being developed for the treatment of Prader-Willi syndrome (PWS), a rare genetic disease characterized by hyperphagia, a chronic unrelenting hunger, that leads to obesity, metabolic dysfunction, reduced quality of life and early mortality. The company is also developing nevanimibe, an ACAT1 inhibitor for the treatment of two orphan adrenal diseases: classic congenital adrenal hyperplasia (CAH) and endogenous Cushing's syndrome (CS).

Contact Information

Formerly Known As
Ovastem
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 9 Fourth Avenue
  • Waltham, MA 02451
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Vertical(s)
Corporate Office
  • 9 Fourth Avenue
  • Waltham, MA 02451
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OvaScience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 07-Dec-2018 Completed Generating Revenue
9. 2PO 26-May-2016 Completed Generating Revenue
8. Secondary Transaction - Open Market 08-Apr-2015 Completed Generating Revenue
7. 2PO 07-Jan-2015 Completed Generating Revenue
6. Secondary Transaction - Open Market 01-Apr-2014 Completed Generating Revenue
5. PIPE 26-Mar-2013 Completed Generating Revenue
4. PIPE 04-Jan-2013 Completed Generating Revenue
3. IPO 12-Nov-2012 Completed Startup
2. Early Stage VC (Series B) 04-Apr-2012 $37.2M $43.4M Completed Startup
1. Early Stage VC (Series A) 11-Oct-2011 $6.2M $6.2M Completed Startup
To view OvaScience’s complete valuation and funding history, request access »

OvaScience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view OvaScience’s complete cap table history, request access »

OvaScience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Millendo Therapeutics Inc is a late-stage biopharmaceutical company focused on developing novel treatments for orphan en
Biotechnology
Waltham, MA
59 As of 2015

Lugano, Switzerland
 

Austin, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OvaScience Competitors (9)

One of OvaScience’s 9 competitors is Adienne, a Corporation company based in Lugano, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adienne Corporation Lugano, Switzerland
XBiotech Corporation Austin, TX
Amgen Formerly PE-Backed Thousand Oaks, CA
Idorsia Pharmaceuticals Corporation Allschwil, Switzerland
Gilead Formerly VC-backed Foster City, CA
You’re viewing 5 of 9 competitors. Get the full list »

OvaScience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OvaScience Former Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Adage Capital Management Hedge Fund Minority
Bessemer Venture Partners Venture Capital Minority
Biobrit Venture Capital Minority
Cycad Group Venture Capital Minority
Deerfield Management Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

OvaScience Acquisitions (1)

OvaScience’s most recent deal was a Reverse Merger with Millendo Therapeutics for . The deal was made on 07-Dec-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Millendo Therapeutics 07-Dec-2018 Reverse Merger Biotechnology
To view OvaScience’s complete acquisitions history, request access »

OvaScience FAQs

  • When was OvaScience founded?

    OvaScience was founded in 2011.

  • Where is OvaScience headquartered?

    OvaScience is headquartered in Waltham, MA.

  • What is the size of OvaScience?

    OvaScience has 59 total employees.

  • What industry is OvaScience in?

    OvaScience’s primary industry is Biotechnology.

  • Is OvaScience a private or public company?

    OvaScience is a Private company.

  • What is OvaScience’s current revenue?

    The current revenue for OvaScience is .

  • How much funding has OvaScience raised over time?

    OvaScience has raised $280M.

  • Who are OvaScience’s investors?

    Adage Capital Management, Bessemer Venture Partners, Biobrit, Cycad Group, and Deerfield Management are 5 of 15 investors who have invested in OvaScience.

  • Who are OvaScience’s competitors?

    Adienne, XBiotech, Amgen, Idorsia Pharmaceuticals, and Gilead are some of the 9 competitors of OvaScience.

  • When was OvaScience acquired?

    OvaScience was acquired on 07-Dec-2018.

  • Who acquired OvaScience?

    OvaScience was acquired by Millendo Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process